BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7091521)

  • 1. Risk factors for the development of distant metastases in patients undergoing pelvic lymphadenectomy for prostatic cancer.
    Schmidt JD; McLaughlin AP; Saltzstein SL; Garcia-Reyes R
    Am J Surg; 1982 Jul; 144(1):131-5. PubMed ID: 7091521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indications for pelvic lymphadenectomy in clinically localized prostate cancer].
    Peneau M; Villers A; Molinié V; Theis D; Soulié M
    Prog Urol; 2004 Jun; 14(3):287-94. PubMed ID: 15373168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
    Terhorst B; Friedrichs R
    Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total submission of pelvic lymphadenectomy tissues removed during radical prostatectomy for prostate cancer increases lymph node yield and detection of micrometastases.
    Perry-Keene J; Ferguson P; Samaratunga H; Nacey JN; Delahunt B
    Histopathology; 2014 Feb; 64(3):399-404. PubMed ID: 24118022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
    Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
    Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study.
    Ramos JG; Caicedo JI; Cataño JG; Villarraga LG; Trujillo CG; Robledo D; Plata M
    Actas Urol Esp; 2016 Sep; 40(7):446-52. PubMed ID: 26995770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The local relapse of prostatic cancer and initial local treatment].
    Maezawa H; Komatsu H; Furuya T; Tago K; Ueno A
    Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1685-9. PubMed ID: 8411824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
    Saltzstein SL; McLaughlin AP
    Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of staging pelvic lymphadenectomy for prostatic cancer.
    Fujioka T; Koike H; Aoki H; Ohhori T; Chiba R; Okamoto S
    Urol Int; 1987; 42(5):380-4. PubMed ID: 3433586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical prostatectomy for stage B2 prostatic cancer.
    Middleton RG; Smith JA
    J Urol; 1982 Apr; 127(4):702-3. PubMed ID: 7069834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant therapy.
    Lange PH; Narayan P
    Urology; 1983 Feb; 21(2):113-8. PubMed ID: 6823718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate.
    Zincke H; Fleming TR; Furlow WL; Myers RP; Utz DC
    Cancer; 1981 Apr; 47(7):1901-10. PubMed ID: 7226084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].
    Feyaerts A; Stainier L; Nollevaux MC; De Groote P; Lorge F; Opsomer R; Wese FX; Cosyns JP; Van Cangh P
    Acta Urol Belg; 1998 Mar; 66(1):1-6. PubMed ID: 9611351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.